Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: ketoconazole

« Back to Dashboard

Summary for Generic Name: ketoconazole

Drug Master File Entries: see list15
Suppliers: see list6
Therapeutic Class:Antifungals

Pharmacology for Ingredient: ketoconazole

Clinical Trials for: ketoconazole

Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.
Status: Completed Condition: Asthma,; Pharmacokinetics,; Cmax,; Tmax,; λz,; AUC,; Ketoconazole,; Metabolite

Ketoconazole Foam 2% for the Treatment of Versicolor
Status: Completed Condition: Tinea Versicolor

Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
Status: Active, not recruiting Condition: Prostate Cancer

Drug Interaction Study of the Effect of Ketoconazole at Steady State on the Pharmacokinetics of a Single Dose of Isavuconazole in Healthy Adult Subjects
Status: Completed Condition: Pharmacokinetics of Isavuconazole; Pharmacokinetics of Ketoconazole; Healthy Adult Volunteers

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
Status: Completed Condition: Cancer

Buprenorphine Accumulation and Description of Its Metabolites During Co-Medication of Buprenorphine Transdermal System (BTDS) and Ketoconazole
Status: Completed Condition: Healthy

Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex
Status: Completed Condition: Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor.

Pharmacokinetics & Tolerability Study of MAP0004 Co-administered With Ketoconazole
Status: Completed Condition: Healthy

Ketoconazole and Dexamethasone in Prostate Cancer
Status: Active, not recruiting Condition: Prostate Cancer

Drug-drug Interaction Study (CKD-501, Ketoconazole)
Status: Completed Condition: Type 2 Diabetes Mellitus

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aaipharma Llc
TABLET;ORAL075341Jul 27, 1999DISCNNo<disabled><disabled>
Perrigo Israel
AEROSOL, FOAM;TOPICAL091550Aug 25, 2011RXNo<disabled><disabled>
Janssen Pharma
SUSPENSION;ORAL070767Nov 7, 1986DISCNNo<disabled><disabled>
Janssen Pharma
CREAM;TOPICAL019084Dec 31, 1985DISCNNo<disabled><disabled>
TABLET;ORAL074971Jun 15, 1999DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn